I was ready to heavily criticize your overly optimistic target price. However, given the corporate travel market is expected to grow to 1,657 Billion by 2023 you may not be too far off.
Still, I find a $40 Billion Mkt Cap hard to contemplate at this stage. Particularly as Serko's growth rates are only just above industry averages.
- Forums
- ASX - By Stock
- Convince me why I should invest in Serko.
I was ready to heavily criticize your overly optimistic target...
Featured News
Add SKO (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.26 |
Change
-0.040(1.21%) |
Mkt cap ! $401.2M |
Open | High | Low | Value | Volume |
$3.30 | $3.30 | $3.26 | $5.795K | 1.768K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 113 | $3.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.47 | 635 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 113 | 3.260 |
1 | 12000 | 2.120 |
1 | 1000 | 1.900 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
3.490 | 168 | 1 |
3.500 | 3000 | 1 |
3.550 | 6999 | 3 |
3.600 | 7684 | 2 |
3.890 | 2459 | 1 |
Last trade - 15.25pm 15/11/2024 (20 minute delay) ? |
Featured News
SKO (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online